Controlling biology with biomaterials: David J. Mooney to talk at BU Thursday, March 13
FOR IMMEDIATE RELEASE:
February 12, 2014
Contact: Jackie Simon
Associate Director of Publications & Media Relations
Boston University Henry M. Goldman
School of Dental Medicine
(Boston) – There are hundreds of clinical trials of cell therapy currently underway, but simple cell infusions lead to large-scale cell death, little control over cell fate, and a typically poor clinical outcome.
In contrast, biomaterials can be used to serve as cell carriers or attractors of host cell populations, and to then program the cells in vivo. David J. Mooney will discuss the potential of biomaterials to regulate cell biology in processes as diverse as tissue regeneration and therapeutic cancer vaccines in the keynote lecture, “Controlling biology with biomaterials: from bone regeneration to cancer vaccines” from 1 to 2 p.m. on Thursday, March 13, 2014, at Boston University Henry M. Goldman School of Dental Medicine’s Science Day in Hiebert Lounge, 72 East Concord Street, 14th floor.
Science Day is a research celebration featuring posters and oral presentations by pre- and post-doctoral dental students, post-doctoral fellows, and faculty and staff. A dental vendor exhibition runs in conjunction with the research presentations. The event is free and open to the public.
Mooney is the Robert P. Pinkas Family Professor of Bioengineering at Harvard School of Engineering and Applied Sciences. He is a Founding Core Faculty Member, Platform Lead, Programmable Nanomaterials at the Wyss Institute for Biologically Inspired Engineering at Harvard.
His laboratory is focused on the design and synthesis of biomaterials that regulate the fate of either cells already resident in the body, or transplanted cell populations.
Dr. Mooney earned a BS in Chemical Engineering at the University of Wisconsin and PhD in Chemical Engineering at the Massachusetts Institute of Technology. He is a member of the National Academy of Engineering and the Institute of Medicine of the National Academies. He has won numerous research awards, and received the Phi Beta Kappa Prize for Excellence in Undergraduate Teaching and the Everett Mendelsohn Excellence in Mentoring Award from Harvard College. His inventions have been licensed by 11 companies, and he is active on industrial scientific advisory boards.
For more information about Science Day, visit bu.edu/dental/scienceday.
About Boston University Henry M. Goldman School of Dental Medicine: Founded in 1963, the Boston University Henry M. Goldman School of Dental Medicine is the premier academic dental institution promoting excellence in dental education, research, oral health care, and community service to improve the overall health of the global population. With a faculty of more than 325 educators, clinicians, and researchers and more than 250 staff members, the School offers a full spectrum of pre-doctoral and post-doctoral specialty education programs and a complete range of graduate programs and degrees to more than 700 students.
About Boston University: Founded in 1839, Boston University is an internationally recognized institution of higher education and research. With more than 33,000 students, it is the fourth-largest independent university in the United States. BU consists of 16 schools and colleges, along with a number of multi-disciplinary centers and institutes integral to the University’s research and teaching mission. In 2012, BU joined the Association of American Universities (AAU), a consortium of 62 leading research universities in the United States and Canada.